Analysis of the Impact of Fintech Firms’ Lending on the Expansion of Service Base Companies in Jordan

The purpose of this research was to analyze the impact of lending by fintech firms on the expansion of service- based companies in Jordan. The studys population included 210 service-based enterprises located in Jordan. The research used a sample size of 136 respondents from registered service-based enterprises in Jordan. The researchers used a structured questionnaire to gather data from the participants. The data acquired in this study were evaluated using a combination of basic percentage calculations and Pearson product moment analysis. The research has reached the conclusion that the lending activities of Fintech firms have a noteworthy impact on the expansion of service-based companies in Jordan. The study suggests that it would be advantageous for the Fintech service provider to engage in advertising efforts aimed at promoting their services, with the goal of increasing the adoption of their mobile money product among a wider range of business professionals. This would lead to an increased number of entrepreneurs using Fintech as a means to augment the expansion of their businesses. The scope of the research was limited to a small number of service-based organizations. However, it is important to include other service-based companies that were not included in this study. To get a comprehensive understanding, a comparison study should be conducted to explore other characteristics that were not addressed in the current research. The field of financial technology (fintech) has seen significant growth in recent years. This growth can be measured by the degree of utilization observed in various fintech applications and services

Product quality and customer perception of pressurized metered dose inhaler (pMDI) manufactured in Bangladesh

This study was aimed to investigate the in-vitro deposition, the market status and the customer’s perception of different pressurized metered dose inhaler (pMDI) preparations, available in Bangladesh. In order to test the efficiency of pMDI, the in-vitro deposition of locally manufactured salmeterol xinafoate from two brands, considered as product A and product B, was carried out using a Twin-Stage-Impinger (TSI) and was correlated with the customer perception. The market status and customer’s perception has been studied through three different market surveys conducted on patients, (n=50), physicians (n=50) and pharmacy shops (n=50). In all three surveys the usage pattern of salbutamol has been found to be highest among various antiasthmatic drugs and has showed market share of 18.2 %. The manufacturer of this product occupied the highest market share compared with those of others. The in-vitro deposition of salmeterol xinafoate from both products revealed that the fine particle fractions (FPF, the amount of deposited salmeterol xinafoate in the lower airway of lung) of these products were within 32-44% and deposition was observed to be higher for product A compared to product B. Both the market status and efficiency testing results indicated that product A showed superior performance and more efficacy compared to the product B

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery

Purpose: This study describes the development and characterization of glucagon dry powder inhaler (DPI) formulation for pulmonary delivery. Lactose monohydrate, as a carrier, and L-leucine and magnesium stearate (MgSt) were used as dispersibility enhancers for this formulation. Methods: Using Fourier-transform infrared (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), and Raman confocal microscopy, the interactions between glucagon and all excipients were characterized. The fine particle fractions (FPFs) of glucagon in different formulations were determined by a twin stage impinger (TSI) using a 2.5% glucagon mixture, and the glucagon concentration was measured by a validated LC-MS/MS method. Results: The FPF of the glucagon was 6.4%, which increased six-fold from the formulations with excipients. The highest FPF (36%) was observed for the formulation containing MgSt and large carrier lactose. The FTIR, Raman, and DSC data showed remarkable physical interactions of glucagon with leucine and a minor interaction with lactose; however, there were no interactions with MgSt alone or mixed with lactose. Conclusion: Due to the interaction between L-leucine and glucagon, leucine was not a suitable excipient for glucagon formulation. In contrast, the use of lactose and MgSt could be considered to prepare an efficient DPI formulation for the pulmonary delivery of glucagon